tiprankstipranks
Tourmaline Bio (TRML)
NASDAQ:TRML
US Market
Holding TRML?
Track your performance easily

Tourmaline Bio (TRML) Financial Statements

474 Followers

Tourmaline Bio Financial Overview

Tourmaline Bio's market cap is currently ―. The company's EPS TTM is $-2.821; its P/E ratio is -9.23; Tourmaline Bio is scheduled to report earnings on March 25, 2025, and the estimated EPS forecast is $-0.88. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -20.18M$ -17.49M$ -17.52M$ -12.97M$ -9.38M
EBITDA$ -20.13M$ -16.26M$ -17.51M$ -10.07M$ -8.26M
Net Income Common Stockholders$ -20.18M$ -17.49M$ -13.31M$ 1.78M$ -7.01M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 281.92M$ 289.53M$ 293.06M$ 202.95M$ 147.02M
Total Assets$ 328.45M$ 344.79M$ 359.17M$ 210.29M$ 151.06M
Total Debt$ 290.00K$ 333.00K$ 376.00K$ 415.00K$ 634.00K
Net Debt$ -281.63M$ -289.20M$ -292.68M$ -202.54M$ -146.39M
Total Liabilities$ 7.38M$ 6.51M$ 5.03M$ 5.25M$ 8.19M
Stockholders Equity$ 321.07M$ 338.28M$ 354.14M$ 205.04M$ 142.87M
Cash Flow-
Free Cash Flow$ -23.44M$ -18.01M$ -14.92M$ 10.86M$ -26.27M
Operating Cash Flow$ -23.44M$ -18.01M$ -14.92M$ 11.02M$ -25.77M
Investing Cash Flow$ -11.70M$ -10.13M$ -188.87M$ -88.42M$ 92.30M
Financing Cash Flow$ -1.00K-$ 161.35M$ 156.46M$ -91.94M
Currency in USD

Tourmaline Bio Earnings and Revenue History

Tourmaline Bio Debt to Assets

Tourmaline Bio Cash Flow

Tourmaline Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis